IMNM - Immunome down 1% prices $200M equity
2024-02-14 02:35:15 ET
More on Immunome
- Immunome: Why It Has Doubled Over The Last Month
- Immunome announces underwritten public offering of common stock
- Immunome to buy AL102, a phase 3 asset for treatment of desmoid tumors
- Seeking Alpha’s Quant Rating on Immunome
- Historical earnings data for Immunome